Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8TEC

Crystal structure of Kindlin2 in complex with acylated beta1 integrin peptide

Summary for 8TEC
Entry DOI10.2210/pdb8tec/pdb
Related5xpy
DescriptorFermitin family homolog 2, Integrin beta-1 (3 entities in total)
Functional Keywordskindlin, integrin, acylation, cell adhesion
Biological sourceMus musculus (house mouse)
More
Total number of polymer chains3
Total formula weight124217.32
Authors
Zhang, P.F.,Wu, J.H. (deposition date: 2023-07-06, release date: 2024-07-03, Last modification date: 2024-10-30)
Primary citationSidibe, A.,Mykuliak, V.V.,Zhang, P.,Hytonen, V.P.,Wu, J.,Wehrle-Haller, B.
Acetyl-NPKY of integrin-beta 1 binds KINDLIN2 to control endothelial cell proliferation and junctional integrity.
Iscience, 27:110129-110129, 2024
Cited by
PubMed Abstract: Integrin-dependent crosstalk between cell-matrix adhesions and cell-cell junctions is critical for controlling endothelial permeability and proliferation in cancer and inflammatory diseases but remains poorly understood. Here, we investigated how acetylation of the distal NPKY-motif of Integrin-β1 influences endothelial cell physiology and barrier function. Expression of an acetylation-mimetic β1-K794Q-GFP mutant led to the accumulation of immature cell-matrix adhesions accompanied by a transcriptomic reprograming of endothelial cells, involving genes associated with cell adhesion, proliferation, polarity, and barrier function. β1-K794Q-GFP induced constitutive MAPK signaling, junctional impairment, proliferation, and reduced contact inhibition at confluence. Structural analysis of Integrin-β1 interaction with KINDLIN2, biochemical pulldown assay, and binding energy determination by using molecular dynamics simulation showed that acetylation of K794 and the K794Q-mutant increased KINDLIN2 binding affinity to the Integrin-β1. Thus, enhanced recruitment of KINDLIN2 to Lysine-acetylated Integrin-β1 and resulting modulation of barrier function, offers new therapeutic possibilities for controlling vascular permeability and disease conditions.
PubMed: 38904068
DOI: 10.1016/j.isci.2024.110129
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.04 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon